Christopher Graham, University of Toronto

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections
New England Journal of Medicine · 2025
COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series.
iScience · 2023
Identification and characterization of invasive multi-drug-resistant (MDR) Bacteroides genomospecies in Canada
Access Microbiology · 2020 · first author

All 4 publications

Latest funding

BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
CIHR · 2025 · Co-investigator
$1,908,674
A Cluster Randomized Cross-over Trial of an Antibiotic Decision Support Intervention in Sepsis (IDEAS II)
CIHR · 2022 · Co-investigator
$300,000
CATCO Scale-Up COVID-19 Supplement - Canadian Treatments for COVID-19: SOLIDARITY
CIHR · 2021 · Co-investigator
$3,500,000

All 4 grants and awards

4 publications.

01

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections

Daneman N, Rishu A, Pinto R, Rogers BA, Shehabi Y, Parke R, Cook D, Arabi Y, Muscedere J, Reynolds S

New England Journal of Medicine2025167 citations

DOI: 10.1056/nejmoa2404991

02

COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series.

Walmsley SL, Szadkowski L, Wouters B, Clarke R, Colwill K, Rochon P, Brudno M, Ravindran R, Raboud J, McGeer A, Oza A, Graham C, Silva A, Manase D, Maksymowsky P, Parente L, Dayam RM, Simpson J, Pasculescu A, Gingras AC

iScience202312 citationsOpen Access

DOI: 10.1016/j.isci.2023.106506 PMID: 37073374

03

Identification and characterization of invasive multi-drug-resistant (MDR) Bacteroides genomospecies in Canada

Christopher Graham, Alireza Eshaghi, Alicia Sarabia, Sandra I. Zittermann, Patrick J. Stapleton, Julianne V. Kus, Samir N. Patel

Access Microbiology20206 citationsFirst authorOpen Access

DOI: 10.1099/acmi.0.000111 PMID: 32974576

04

Exploring protein phosphorylation in response to DNA damage using differentially tagged yeast arrays.

Suter B, Graham C, Stagljar I

BioTechniques20084 citationsOpen Access

DOI: 10.2144/000112949 PMID: 19007343

BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections

Co-investigatorCIHR2025Project Grant

Principal investigators: Daneman, Nick; Fowler, Robert A; Johnstone, Jennie; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Ong, Sean W; Pinto, Ruxandra; Rogers, Benjamin A

Keywords: Adaptive Platform Trial; Antibiotic De-Escalation; Antibiotic Duration; Antibiotic Oral Switch; Antimicrobial Resistance; Bloodstream Infection; Central Venous Catheter Infection; Gram Negative Bacteremia; Randomized Clinical Trial

$1,908,674

A Cluster Randomized Cross-over Trial of an Antibiotic Decision Support Intervention in Sepsis (IDEAS II)

Co-investigatorCIHR2022Project Grant - PA: ECR Antimicrobial Resistance Multi-Year Grant

Principal investigators: MacFadden, Derek R; Daneman, Nick

Keywords: Antibiotic Prescribing; Clinical Decision Support; Cluster Randomized Trial; Sepsis

$300,000

CATCO Scale-Up COVID-19 Supplement - Canadian Treatments for COVID-19: SOLIDARITY

Co-investigatorCIHR2021Operating Grant: CATCO Scale-Up COVID-19 Supplement Funding Opportunity

Principal investigators: Murthy, Srinivas; Fowler, Robert A

Keywords: Clinical Characterization; Knowledge Translation; Randomized Clinical Trial; Stakeholder Perspectives

$3,500,000

Safety and Efficacy of Preventative COVID Vaccines- STOPCoV ( Phase 2)

Co-investigatorCIHR2021Op. Gr: Emer. COVID Res. Gaps/Prior- Dif. Impacts on Hist. Excl/Underserved Pops

Principal investigators: Walmsley, Sharon L; Gingras, Anne-Claude; Rochon, Paula A

Keywords: Age; Antibody; Booster; Covid; Dried Blood Spots; Prospective Cohort; Safety; Serology; Vaccine

$499,135

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Deborah Cook and John Marshall: 112 shared papers
Deborah Cook and François Lamontagne: 105 shared papers
Deborah Cook and John Muscedere: 104 shared papers
Deborah Cook and Erick Duan: 83 shared papers
Anne-Claude Gingras and Allison McGeer: 60 shared papers
Deborah Cook and Jennifer Tsang: 52 shared papers
Jennifer Tsang and Erick Duan: 49 shared papers
François Lamontagne and John Marshall: 49 shared papers
Lauralyn McIntyre and John Marshall: 49 shared papers
Emilie Belley-Cote and François Lamontagne: 43 shared papers
John Marshall and John Muscedere: 41 shared papers
François Lamontagne and John Muscedere: 40 shared papers
Deborah Cook and Ian Ball: 35 shared papers
Erick Duan and François Lamontagne: 35 shared papers
Deborah Cook and Lauralyn McIntyre: 34 shared papers
Jennifer Tsang and François Lamontagne: 33 shared papers
Deborah Cook and Emilie Belley-Cote: 31 shared papers
John Muscedere and Ian Ball: 31 shared papers
Erick Duan and Emilie Belley-Cote: 26 shared papers
John Marshall and Anand Kumar: 25 shared papers
Allison McGeer and Julianne Kus: 24 shared papers
Bradly Wouters and Amit Oza: 23 shared papers
François Lamontagne and Lauralyn McIntyre: 22 shared papers
François Lamontagne and Ian Ball: 22 shared papers
Janet Raboud and Allison McGeer: 21 shared papers
Deborah Cook and Anand Kumar: 13 shared papers
François Lamontagne and Anand Kumar: 13 shared papers
Andrew Morris and Allison McGeer: 12 shared papers
Allison McGeer and Bryan Coburn: 11 shared papers
Michael Brudno and Bradly Wouters: 7 shared papers
Michael Brudno and Amit Oza: 7 shared papers
Deborah Cook and John Neary: 6 shared papers
Jennifer Tsang and John Neary: 6 shared papers
Jennifer Tsang and Bryan Coburn: 6 shared papers
John Neary and Emilie Belley-Cote: 6 shared papers
Erick Duan and Bryan Coburn: 6 shared papers
Jennifer Tsang and Alex Carignan: 5 shared papers
Anne-Claude Gingras and Igor Stagljar: 5 shared papers
Anne-Claude Gingras and Michael Brudno: 5 shared papers
Anne-Claude Gingras and Bradly Wouters: 5 shared papers
Allison McGeer and John Conly: 5 shared papers
John Muscedere and Alex Carignan: 5 shared papers
Anne-Claude Gingras and Janet Raboud: 4 shared papers
Anne-Claude Gingras and Amit Oza: 4 shared papers
Janet Raboud and Michael Brudno: 4 shared papers
Andrew Morris and Bryan Coburn: 4 shared papers
John Conly and Gerald Evans: 4 shared papers
Deborah Cook and Alex Carignan: 3 shared papers
Jennifer Tsang and John Conly: 3 shared papers
Jennifer Tsang and Gerald Evans: 3 shared papers
Erick Duan and Gerald Evans: 3 shared papers
Jennifer Tsang and Andrew Morris: 2 shared papers
Igor Stagljar and Allison McGeer: 2 shared papers
Deborah Cook and Christopher Graham: 1 shared paper
Jennifer Tsang and Christopher Graham: 1 shared paper
John Neary and Christopher Graham: 1 shared paper
Erick Duan and Christopher Graham: 1 shared paper
Emilie Belley-Cote and Christopher Graham: 1 shared paper
Anne-Claude Gingras and Christopher Graham: 1 shared paper
Janet Raboud and Christopher Graham: 1 shared paper
François Lamontagne and Christopher Graham: 1 shared paper
Igor Stagljar and Christopher Graham: 1 shared paper
Michael Brudno and Christopher Graham: 1 shared paper
Lauralyn McIntyre and Christopher Graham: 1 shared paper
Andrew Morris and Christopher Graham: 1 shared paper
Allison McGeer and Christopher Graham: 1 shared paper
Bradly Wouters and Christopher Graham: 1 shared paper
John Marshall and Christopher Graham: 1 shared paper
Bryan Coburn and Julianne Kus: 1 shared paper
Bryan Coburn and Christopher Graham: 1 shared paper
Anand Kumar and Christopher Graham: 1 shared paper
John Conly and Christopher Graham: 1 shared paper
John Muscedere and Christopher Graham: 1 shared paper
Julianne Kus and Christopher Graham: 1 shared paper
Amit Oza and Christopher Graham: 1 shared paper
Ian Ball and Christopher Graham: 1 shared paper
Gerald Evans and Christopher Graham: 1 shared paper
Christopher Graham and Alex Carignan: 1 shared paper

Department of Medicine
Department of Laboratory Medicine & Pathobiology
Département de microbiologie et d'infectiologie
Department of Molecular Genetics
Department of Radiation Oncology
FMSS Département de médecine
Department of Epidemiology and Biostatistics
Other

1 shared papers, latest 2025

Peter Dodek

Department of Medicine

1 shared papers, latest 2025

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Graham, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections" (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Christopher Graham

Research

Latest papers

Latest funding

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections

COVID-19 vaccine antibody responses in community-dwelling adults to 48&#xa0;weeks post primary vaccine series.

Identification and characterization of invasive multi-drug-resistant (MDR) Bacteroides genomospecies in Canada

Exploring protein phosphorylation in response to DNA damage using differentially tagged yeast arrays.

BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections

A Cluster Randomized Cross-over Trial of an Antibiotic Decision Support Intervention in Sepsis (IDEAS II)

CATCO Scale-Up COVID-19 Supplement - Canadian Treatments for COVID-19: SOLIDARITY

Safety and Efficacy of Preventative COVID Vaccines- STOPCoV ( Phase 2)

Frequent collaborators

Alex Carignan

Pierre Aslanian

Deborah Cook

Jennifer Tsang

John Neary

Erick Duan

Emilie Belley-Cote

Nishma Singhal

Anne-Claude Gingras

Ryan Zarychanski

Janet Raboud

François Lamontagne

Igor Stagljar

Michael Brudno

Lauralyn McIntyre

Claudio Martin

Andrew Morris

Paula Rochon

Allison McGeer

Bradly Wouters

Nick Daneman

Peter Dodek

COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series.